Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02849652 · ClinicalTrials.gov registry record · NA

Testing an Organizational Change Model to Address Smoking in Mental Healthcare

A NA study of Nicotine Dependence, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
832
Enrollment target
1
Study location

NCT02849652: Completed NA study of Nicotine Dependence, sponsored by University of Pennsylvania.

NCT02849652 is a NA study of Nicotine Dependence that has completed, run by University of Pennsylvania. The registered enrollment target is 832 participants, above the 174-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (378% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02849652, a NA study of Nicotine Dependence, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
832 participants
Enrollment target
1
Study location

Study Summary

Despite an overall reduction in US smoking rates from \>50% in the 1960s to about 20% by 2000, the rate of smoking among persons with a serious mental illness (SMI) remains 2-3 times greater than in the general population. Further, even the recent small decline in smoking rates that has been reported in the general population in the past decade has not occurred among smokers with an SMI. In fact, 44% of all the cigarettes consumed in the US are by individuals with a psychiatric disorder and the primary cause of death among Americans with an SMI is a tobacco-related disease. This cluster randomized trial will be conducted in 14 Philadelphia community mental health clinics (CMHCs). Clinics will be randomized to either Addressing Tobacco Through Organizational Change model (ATTOC) or Usual Care (UC) treatment groups. The investigators hypothesize that 1) at the end of the intervention and at a 3-month follow-up, rates of adherence to guidelines for treating TUD will be greater among clinic personnel that receive the ATTOC intervention vs. clinic personnel in usual care; 2) at the end of the intervention and at a 3-month follow-up, rates of client smoking cessation will be significantly greater in clinics that receive the ATTOC intervention than among clients treated with usual care; and 3) using non-inferiority testing, at the end of the intervention and at a 3-month follow-up, there will be no significant degradation in mental health functioning or QOL among clients who receive care at clinics that received the ATTOC intervention than among clients treated with usual care.

Primary Outcome

Client-reported use of tobacco treatment for nicotine dependence measured via self-report

Conditions Studied

Interventions

  • BEHAVIORAL ATTOC Intervention
  • BEHAVIORAL UC Intervention

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 832 participants
Start Date 2016-07
Est. Completion 2022-12
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT02849652 record still lists

NCT02849652 is an interventional study that assigns participants to a tested intervention. The registered 832 participants enrollment target is mid-sized for trials with a published cap, above the 174-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (378% higher).

The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which ATTOC Intervention is the first listed.

NCT02849652 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02849652 about?

NCT02849652 is a clinical study titled "Testing an Organizational Change Model to Address Smoking in Mental Healthcare". Despite an overall reduction in US smoking rates from \>50% in the 1960s to about 20% by 2000, the rate of smoking among persons with a serious mental illness (SMI) remains 2-3 times greater than in the general population. Further, even the recent small decline in smoking rates that has been reporte...

What is the current status of trial NCT02849652?

This trial is currently completed. It is a NA study. The enrollment target is 832 participants. The study started on 2016-07. Estimated completion is 2022-12.

What conditions does trial NCT02849652 study?

This clinical trial studies the following conditions: Nicotine Dependence.

What interventions are being tested in trial NCT02849652?

The interventions under investigation include: ATTOC Intervention (BEHAVIORAL), UC Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02849652?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02849652 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02849652's enrollment target sits among peer trials

832 3rd of 67 higher than 65 of 67 other Nicotine Dependence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06910553 · 832 participants

    IBD Pregnancy Registry

  • NCT07089706 · 832 participants · Phase 4

    A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

  • NCT05067283 · 830 participants · Phase 1

    A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

  • NCT06592924 · 830 participants · Phase 3

    Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02849652, the US trial registry maintained by the National Library of Medicine. NCT02849652 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.